PPARA and hepatocellular carcinoma: LINC00467, another lncRNA that was found to be downregulated in HCC, has been studied as a potential therapeutic target thanks to its role as an antagomir for miR-9-5a, which targets peroxisome proliferator-activated receptor alpha (PPARA) for silencing [140].